Navigation Links
Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
Date:11/20/2007

PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- The American Society of Consultant Pharmacists (ASCP) announces that Outcomes Pharmaceutical Health Care(r) (Outcomes(r)) has become one of ASCP's Medication Therapy Management (MTM) Provider Partners. This announcement was made today at Senior Care Pharmacy '07 -- ASCP's 38th Annual Meeting and Exhibition taking place in Philadelphia.

The need for skilled clinicians to deliver MTM services has increased dramatically since the coverage of MTM services under Medicare Part D, especially for patients residing outside of nursing facilities. ASCP's MTM Provider Partners, recognizing the excellence of ASCP members, turned to the Society to help them enlist consultant and senior care pharmacists to deliver MTM services to their contracted enrollees.

Consultant and senior care pharmacists are clinicians specially trained in geriatric pharmacotherapy who review patients' medication regimens to ensure they are receiving the most appropriate, safe, and most effective medications, and that they are used appropriately. Further, consultant and senior care pharmacists identify individuals at high risk for medication-related problems, and identify and resolve health problems that are not otherwise recognized as medication-related.

"This new partnership will expand the reach of ASCP member consultant and senior care pharmacists into community-based settings, bringing much needed clinical expertise to medically complex patients wherever they reside," said ASCP Executive Director & CEO John Feather.

Since 1999, Outcomes has specialized in delivering MTM services to patients covered under employer sponsored health benefits, Medicare Part D plans, Medicaid programs, health plans, union funds, pharmacy benefits managers, disease management firms, case management companies, and various managed care organizations.

"Across the nation, more than two million patients are eligible for Outcomes MTM programs," said Patty Kumbera, Chief Operating Officer, Outcomes Pharmaceutical Health Care(r). "We are excited to partner with ASCP to expand our network. ASCP members will join thousands of Outcomes Personal Pharmacists providing face to face MTM services, including comprehensive medication reviews, cost efficacy management, drug therapy problem resolution, and patient consultations."

"ASCP's MTM Provider Partners offer our members a unique path for providing clinical services in the community setting," said ASCP's Feather. "This has been a membership desire for some time, and we are pleased to add ASCP'S MTM Provider Partners to our roster of member benefits."

The American Society of Consultant Pharmacists, the recognized expert in geriatric pharmacotherapy, is the international professional association that provides leadership, education, advocacy, and resources to advance the practice of consultant and senior care pharmacy. ASCP's 8,000 members manage and improve drug therapy and improve the quality of life of geriatric patients and other individuals residing in a variety of environments, including nursing facilities, subacute care and assisted living facilities, psychiatric hospitals, hospice programs, and in-home and community-based care. Visit ASCP's Web site at http://www.ascp.com.


'/>"/>
SOURCE American Society of Consultant Pharmacists
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Continued Statin Use Boosts Post-Stroke Outcomes
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. QI projects may -- or may not -- improve patient safety and outcomes
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Bypass Off-Pump Boosts Womens Outcomes
7. Mayo Clinic study indicates medication for ADHD may help student outcomes
8. Experts Compare Colon Cancer Treatment Outcomes
9. Gene Chip Data Can Boost Cancer Outcomes
10. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
11. Studies suggest key correlation between lung cancer subtype and treatment outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research ... Li completed his internship in internal medicine at the Emory University and dermatology ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details What ... areas are going to grow at the fastest rates? ... assessing data, trends, opportunities and prospects. Our 190-page ... most lucrative areas in the industry and the future ... sales across the all the major categories of the ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
Breaking Medicine Technology: